Detalhe da pesquisa
1.
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II).
Lancet
; 401(10381): 1011-1019, 2023 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36848919
2.
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
Ann Rheum Dis
; 83(1): 15-29, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827694
3.
Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Ann Rheum Dis
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754981
4.
Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
N Engl J Med
; 382(3): 211-221, 2020 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31851795
5.
Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes.
Ann Rheum Dis
; 82(7): 927-936, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37085289
6.
Determinants of health-related quality of life across the spectrum of connective tissue diseases using latent profile analysis: results from the LEAP cohort.
Rheumatology (Oxford)
; 62(8): 2673-2682, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36534822
7.
Sustained glucocorticoid tapering in the phase 3 trials of anifrolumab: a post hoc analysis of the TULIP-1 and TULIP-2 trials.
Rheumatology (Oxford)
; 62(4): 1526-1534, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36018235
8.
Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine.
Rheumatology (Oxford)
; 62(3): 1124-1135, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35766806
9.
The BILAG-2004 index is associated with development of new damage in SLE.
Rheumatology (Oxford)
; 62(2): 668-675, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35686924
10.
Systemic lupus erythematosus phenotypes formed from machine learning with a specific focus on cognitive impairment.
Rheumatology (Oxford)
; 62(11): 3610-3618, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36394258
11.
Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus.
Clin Proteomics
; 20(1): 29, 2023 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37516862
12.
Predictors of British Isles Lupus Assessment Group-based outcomes in patients with systemic lupus erythematosus: Analysis from the Systemic Lupus International Collaborating Clinics Inception Cohort.
Lupus
; 32(9): 1043-1055, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37463793
13.
Valuing Health Gain from Composite Response Endpoints for Multisystem Diseases.
Value Health
; 26(1): 115-122, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36008224
14.
Longitudinal analysis of urinary proteins in lupus nephritis - A pilot study.
Clin Immunol
; 236: 108948, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123058
15.
Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials.
Ann Rheum Dis
; 81(7): 962-969, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35580976
16.
Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials.
Ann Rheum Dis
; 81(7): 951-961, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338035
17.
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.
Ann Rheum Dis
; 81(6): 768-779, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35110331
18.
Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Ann Rheum Dis
; 81(11): 1541-1548, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944946
19.
Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
Ann Rheum Dis
; 81(8): 1143-1150, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338033
20.
Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Ann Rheum Dis
; 81(3): 370-378, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34911705